Swiss Eye Care Enterprise Alcon Sets Sights On Asian Expansion With New Singapore Plant
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Swiss eye care products developer Alcon has started building its first Asian pharmaceutical plant in Singapore, with the $160-million facility slated to begin operating in 2013